መነሻ › ካንሰር (ሁሉም ዓይነቶች) › Ohio › Cincinnati
በCincinnati፣ OH ለካንሰር (ሁሉም ዓይነቶች) የሚደረጉ ክሊኒካዊ ጥናቶች
ለካንሰር (ሁሉም ዓይነቶች) የሚደረጉ 27 ጥናቶች በCincinnati እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Cincinnati Medical Center. /ID# 278925, Cincinnati
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Oncology Hematology Care Clinical Trials, LLC, Fairfield · 15 ማይል ርቀት
Registry Study for Radiation Therapy Outcomes
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- University of Cincinnati Medical Center, Cincinnati
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Saint Elizabeth Medical Center Edgewood, Edgewood · 8 ማይል ርቀት
A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer
ተሳታዮችን በመፈለግ ላይ
- Cincinnati Children's Hospital Medical Center, Cincinnati
Pan Tumor Rollover Study
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Oncology Hematology Care, Cincinnati
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Oncology Hematology Care - Fairfield /ID# 280641, Fairfield · 15 ማይል ርቀት
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Cincinnati Medical Center, Cincinnati
- West Chester Hospital, West Chester · 15 ማይል ርቀት
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Oncology Hematology Care, Inc., Cincinnati
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Edgewood · 8 ማይል ርቀት
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- USO - Oncology Hematology Care, Cincinnati
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- University of Cincinnati, Cincinnati
Project: Every Child for Younger Patients With Cancer
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Cincinnati Children's Hospital Medical Center, Cincinnati
International Rare Brain Tumor Registry
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Cincinnati Children's Hospital Medical Center, Cincinnati
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- እና 1 ተጨማሪ
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- University of Cincinnati Physicians Group, LLC, Cincinnati
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Oncology Hematology Care - Blue Ash /ID# 272918, Cincinnati
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University Of Cincinnati Medical Center /ID# 251746, Cincinnati
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- TriHealth Cancer Institute, Cincinnati
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- University of Cincinnati, Cincinnati
Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Cincinnati Medical Center, Cincinnati
GEMINI-NSCLC: NSCLC Biomarker Study
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- TriHealth Cancer Institute, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Massive Bio SYNERGY-AI site, Cincinnati
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
ተሳታዮችን በመፈለግ ላይደረጃ 1
- The Christ Hospital Cancer Center, Cincinnati
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- University of Cincinnati Medical Center, Cincinnati
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- TriHealth Cancer Institute, Cincinnati
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
ተሳታዮችን በመፈለግ ላይ
- University of Cincinnati, Cincinnati
- West Chester Hospital (OH394), West Chester · 15 ማይል ርቀት
በሌሎች ከተሞች ለካንሰር (ሁሉም ዓይነቶች) የሚደረጉ ጥናቶች
- Houston, TX121 ጥናቶች
- New York City, NY110 ጥናቶች
- Boston, MA86 ጥናቶች
- Los Angeles, CA73 ጥናቶች
- Nashville, TN65 ጥናቶች
- Philadelphia, PA59 ጥናቶች
- Durham, NC58 ጥናቶች
- Washington, DC58 ጥናቶች
- Chicago, IL51 ጥናቶች
- Seattle, WA49 ጥናቶች
- Atlanta, GA49 ጥናቶች
- Arlington, VA48 ጥናቶች
በCincinnati ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር35 ጥናቶች
- የጡንቻ ካንሰር25 ጥናቶች
- የልብ ድካም24 ጥናቶች
- የኮሎሬክታል ካንሰር21 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ20 ጥናቶች
- Metastatic Cancer20 ጥናቶች
- የእንቁላል ካንሰር19 ጥናቶች
- የሳንባ ካንሰር19 ጥናቶች
- ከባድ ሰውነት19 ጥናቶች
- የፕሮስቴት ካንሰር18 ጥናቶች
- Multiple Myeloma17 ጥናቶች
- ሜላኖማ17 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።